title: Amyloid protein in somatostatinoma differs from human islet amyloid polypeptide.
abstract: Amyloid deposits in somatostatinomas are rare observations. To examine the characteristics of this amyloid, we compared amyloid deposits in a somatostatinoma to those found in pancreatic tissue in patients with Type II diabetes mellitus and in insulinomas, using immunohistochemical techniques and specific antibodies to islet amyloid polypeptide or other pancreatic hormones, as well as electron-microscopy. Antibodies to islet amyloid polypeptide regions 8-17 or 25-37 were confirmed to be specific. Amyloid deposits in patients with Type II diabetes mellitus and in insulinomas, but not those in the somatostatinoma strongly reacted with these antibodies, or to an antibody to amyloid P component. Amyloid deposits in the somatostatinoma were not reactive with antibodies to somatostatin or to other pancreatic hormones. Electron-microscopic examinations revealed that amyloid fibrils in the somatostatinoma were thinner and more randomly distributed than were those in islets from patients with Type II diabetes mellitus. As amyloid in somatostatinomas is unlike that consisting of islet amyloid polypeptide or other mature pancreatic hormones, it may be a novel type of local amyloid in pancreatic islets.
authors.affiliation: Second Department of Internal Medicine, Chiba University School of Medicine, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Ohsawa
authors.forename: A
authors.initials: A
authors.lastname: Kanatsuka
authors.forename: Y
authors.initials: Y
authors.lastname: Tokuyama
authors.forename: T
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: H
authors.initials: H
authors.lastname: Makino
authors.forename: S
authors.initials: S
authors.lastname: Yoshida
authors.forename: H
authors.initials: H
authors.lastname: Horie
authors.forename: A
authors.initials: A
authors.lastname: Mikata
authors.forename: Y
authors.initials: Y
authors.lastname: Kohen
mesh_terms: D000328:Adult; D000368:Aged; D000682:Amyloid / Q000378:metabolism* / Q000648:ultrastructure; D000906:Antibodies / Q000276:immunology; D000918:Antibody Specificity; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007340:Insulinoma / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D058228:Islet Amyloid Polypeptide; D007515:Islets of Langerhans / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D010179:Pancreas / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D010187:Pancreatic Hormones / Q000276:immunology / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure; D000683:Serum Amyloid P-Component / Q000276:immunology / Q000378:metabolism; D013005:Somatostatinoma / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure
chemical_list: D000682:Amyloid; D000906:Antibodies; D058228:Islet Amyloid Polypeptide; D010187:Pancreatic Hormones; D000683:Serum Amyloid P-Component